Hair Loss News and Research

RSS

Microbiome 'profiling' may help identify people at risk of long COVID

The make-up of the gut microbiome may be linked to a person's risk of developing 'long COVID' many months after initial infection with SARS-CoV-2, the virus responsible for COVID-19 infection, suggests research published online in the journal Gut.

26 Jan 2022

Females more prone to long-term post-COVID-19 symptoms

In a recent study published in the Journal of Clinical Medicine, researchers described the results of a multi-center study (LONG-COVID-EXP-CM) that investigated sex differences in coronavirus disease 2019 (COVID-19)-related symptoms and long-term post-COVID-19 symptoms in a group of previously hospitalized COVID-19 survivors in a large Spanish population.

19 Jan 2022

Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes

Individuals living with type 1 diabetes must carefully follow prescribed insulin regimens every day, receiving injections of the hormone via syringe, insulin pump or some other device. And without viable long-term treatments, this course of treatment is a lifelong sentence.

18 Jan 2022

New method may help make immunomodulation more effective in individuals with Type 1 diabetes

Individuals living with Type 1 diabetes must carefully follow prescribed insulin regimens every day, receiving injections of the hormone via syringe, insulin pump or some other device. And without viable long-term treatments, this course of treatment is a lifelong sentence.

17 Jan 2022

Comparison of COVID-19 and influenza-associated complications

Researchers compare the number, types, and risk for complications among COVID-19 and influenza patients using claims data.

9 Jan 2022

Engineering hairy cellulose nanocrystals to capture chemotherapy drugs

Millions of people around the globe are affected by cancer each year; more than 39% of men and women are diagnosed with cancer during their lifetime.

7 Jan 2022

Persistence of symptoms up to a year after hospitalization for COVID-19

Researchers conducted a prospective cohort study to determine the persisting COVID-19 associated symptoms after hospitalization and their risk factors.

15 Dec 2021

Researchers identify new drug that makes pancreatic cancer cells more vulnerable to chemotherapy

Researchers at Washington University School of Medicine in St. Louis have identified a drug compound that makes pancreatic cancer cells more vulnerable to chemotherapy.

1 Dec 2021

Teriflunomide tempers lesion growth in pediatric patients with multiple sclerosis

There are few treatment options for children with multiple sclerosis - a condition in which the immune system attacks the protective covering of nerves in the brain and spinal cord - and most therapies for the disease have not been tested in children.

30 Nov 2021

Using the contraceptive pill to reduce risk of type-2 diabetes in women with PCOS

In this interview, News-Medical speaks to Professor Weibke Arlt about her recent research into how the contraceptive pill affects type 2 diabetes in women with PCOS.

22 Nov 2021

SARS-CoV-2 vaccination lowers risk of several outcomes after breakthrough infection

Researchers at the University of Oxford have conducted a study showing that vaccination against coronavirus disease 2019 (COVID-19) is associated with a lower risk of several sequelae among those who experience breakthrough infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Oct 2021

Post COVID-19 affects children as well as adults

A new study presents data on long covid in adults and children, which is becoming a major issue in public health planning.

26 Oct 2021

Contraceptive pill can reduce the risk of type 2 diabetes in women with PCOS, study reveals

A study led by the University of Birmingham has revealed for the first time that the contraceptive pill can reduce the risk of type 2 diabetes by over a quarter in women with polycystic ovary syndrome (PCOS).

15 Oct 2021

Chemotherapy Patients Benefit from Optimum Coolant Flow During Treatment

Titan Enterprises celebrates over 10 years of partnership development with Paxman Coolers Ltd (www.paxmanscalpcooling.com) as the company reports over 4,000 Paxman scalp-cooling systems are now installed around the world, reducing the likelihood of chemotherapy-induced alopecia.

From Titan Enterprises Ltd 15 Oct 2021

More than half of COVID-19 survivors experience "long COVID", researchers say

More than half of the 236 million people who have been diagnosed with COVID-19 worldwide since December 2019 will experience post-COVID symptoms - more commonly known as "long COVID" - up to six months after recovering, according to Penn State College of Medicine researchers.

13 Oct 2021

Hair Loss News and Research

Microbiome 'profiling' may help identify people at risk of long COVID

Females more prone to long-term post-COVID-19 symptoms

Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes

New method may help make immunomodulation more effective in individuals with Type 1 diabetes

Comparison of COVID-19 and influenza-associated complications

Engineering hairy cellulose nanocrystals to capture chemotherapy drugs

Persistence of symptoms up to a year after hospitalization for COVID-19

Researchers identify new drug that makes pancreatic cancer cells more vulnerable to chemotherapy

Teriflunomide tempers lesion growth in pediatric patients with multiple sclerosis

Using the contraceptive pill to reduce risk of type-2 diabetes in women with PCOS

SARS-CoV-2 vaccination lowers risk of several outcomes after breakthrough infection

Post COVID-19 affects children as well as adults

Contraceptive pill can reduce the risk of type 2 diabetes in women with PCOS, study reveals

Chemotherapy Patients Benefit from Optimum Coolant Flow During Treatment

More than half of COVID-19 survivors experience "long COVID", researchers say

Health-related quality of life of COVID-19 patients with long-COVID: Study

Study finds even individuals with mild COVID-19 suffer from long-COVID

New treatment approaches offer hope to minimize hair thinning in middle-aged women

High-fat diet or genetically induced obesity can lead to loss of hair follicles

Low-level laser treatment can stimulate hair follicles and hair growth, expert finds

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News